PharmAbcine Inc - ESG Rating & Company Profile powered by AI
The assessment of PharmAbcine Inc employs intelligence from across the internet and also from public disclosures by PharmAbcine Inc. The analysis of PharmAbcine Inc is assembled by All Street Sevva using leading machine learning. This Disclosure score covers seventeen United Nations SDGs including: 'Clean Water & Sanitation', 'Climate Action' and 'Life below Water'.
PharmAbcine Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1967 | Hospira Inc | 0.3 | Low |
| 1967 | PRA Health Sciences Inc | 0.3 | Low |
| 1970 | PharmAbcine Inc | 0.0 | Low |
| 1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
| 1970 | CTC Bio Inc | 0.0 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does PharmAbcine Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes PharmAbcine Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes PharmAbcine Inc report the average age of the workforce?
Sign up for free to unlockDoes PharmAbcine Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes PharmAbcine Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes PharmAbcine Inc disclose cybersecurity risks?
Sign up for free to unlockDoes PharmAbcine Inc offer flexible work?
Sign up for free to unlockDoes PharmAbcine Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes PharmAbcine Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes PharmAbcine Inc conduct supply chain audits?
Sign up for free to unlockDoes PharmAbcine Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes PharmAbcine Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes PharmAbcine Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes PharmAbcine Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes PharmAbcine Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes PharmAbcine Inc disclose water use targets?
Sign up for free to unlockDoes PharmAbcine Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid PharmAbcine Inc have a product recall in the last two years?
Sign up for free to unlockDoes PharmAbcine Inc disclose incidents of discrimination?
Sign up for free to unlockDoes PharmAbcine Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas PharmAbcine Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes PharmAbcine Inc disclose parental leave metrics?
Sign up for free to unlockDoes PharmAbcine Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes PharmAbcine Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes PharmAbcine Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes PharmAbcine Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes PharmAbcine Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes PharmAbcine Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs PharmAbcine Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes PharmAbcine Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes PharmAbcine Inc disclose its waste policy?
Sign up for free to unlockDoes PharmAbcine Inc report according to TCFD requirements?
Sign up for free to unlockDoes PharmAbcine Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes PharmAbcine Inc disclose energy use targets?
Sign up for free to unlockDoes PharmAbcine Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes PharmAbcine Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for PharmAbcine Inc
These potential risks are based on the size, segment and geographies of the company.
PharmAbcine, Inc., a biotechnology company, develops human therapeutic monoclonal antibody (mAb) for the treatment of cancer and inflammatory diseases. It focuses primarily on the out-licensing of candidate therapeutics and clinical applications. The company develops TTAC0001, a human anti-angiogenic mAb against VEGFR-2(KDR); and dual specific antibody technologies, including DIG-body and PIG-body for therapeutic use. PharmAbcine, Inc. has a strategic partnership with Samsung Biologics Co.,Ltd. for the development and manufacturing of PMC-403 pipeline, a therapeutic antibody candidate to treat neovascular disorders; and a research collaboration agreement with LegoChem Biosciences Inc. (LCB) to provide PMC-403, a preclinical pipeline to LCB for a combination research using PMC-403 and LCB's ADC for solid tumors. The company is headquartered in Daejeon, South Korea.